George Perry

Chief Science Officer
George Perry, Ph.D.

Professor of Biology
Dean College of Sciences
University of Texas at San Antonio
San Antonio, Texas


Ph.D., Marine Biology, Scripps Institution of Oceanography, University of California at San Diego
Postdoctoral Fellow, Department of Cell Biology, Baylor College of Medicine, Houston, Texas

Dr. Perry joined the UTSA faculty in 2006 from Case Western Reserve University where he was Professor of Pathology and Neurosciences and Chair of the Department of Pathology. He is also distinguished as one of the top 20 Alzheimer’s disease researchers with over 800 publications, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in Free Radical research . He currently serves as and President for the American Association of Neuropathologists. He is on the editorial board of over 60 journals including American Journal of Pathology and Journal of Biological Chemistry, and is Editor-in-Chief of Journal of Alzheimer’s Disease.

Research Interests

Our studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. We have shown that oxidative damage is the initial cytopathology in Alzheimer disease. We are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. Our current studies focus on (i) the mechanism for RNA-based redox metal binding; (ii) the consequences of RNA oxidation on protein synthesis rate and fidelity; (iii) the role of redox active metals in mediating prooxidant and antioxidant properties; (iv) the signal transduction pathways altered in Alzheimer’s disease that allow neurons to evade apoptosis; and (v) mechanism of phosphorylation control of oxidative damage to neurofilament proteins.

Ma Gloria Borras-Boneu

Ma Gloria Borras-Boneu, M.D.

GRD Health Institute
Barcelona, Spain

Dr. Borras-Boneu graduated from the Medical School of Barcelona in 1980. She developed her research in Immunology and Enzymes in Chronic Diseases, and specialized in Women’s Health. She stayed at the MD Anderson Cancer Center at Houston, University of Texas, and afterwards as Research Fellow in Harvard Medical School, to work in Endocrinology and Immunobiology of human neoplasms. At Harvard University she started the disciplines of mind and body coordination, with breathing, movement and mental focusing.

By 1990 she came back to Barcelona and worked as a hospital medical doctor, where she taught and participated in research. She kept up her oriental practice which allowed her to receive training as a Kundalini Yoga and Sat Nam Rasayan Meditation Teacher.

After 2000 she developed her practice in the Corachan Clinic and started the Consciousness, Health and Medicine program in the GRD Medic Health Institute. She is a member of the Scientific Advisory Council for the Alzheimer’s Research and Prevention Foundation in Tucson (USA). She collaborates in the GRD Centre for Medicine and Humanology Foundation in Espanola (USA), and is a member of the section for Natural Medicine in COMB and the Medical Sciences Academy of Catalonia and Balearic islands.

Hiroko H. Dodge, Ph.D.

Hiroko H. Dodge, Ph.D.

Dr. Dodge has been directing two Alzheimer's Disease (AD) Centers' Data Cores jointly: the NIA-funded Layton Aging and Alzheimer's Disease Center (ADC) at Oregon Health &Science University (OHSU) and the Michigan ADC. She has over 20 years of experience working as a statistician in the field of dementia research. In addition to her statistical expertise, her research interests cover a wide range of areas, including epidemiology of dementia, cross cultural comparisons on healthy aging between Okinawa, Japan and Oregon collaborating with the Okinawa Centenarian Study project, application of demographic methods to clinical research, longitudinal data analyses and clinical trial methods. She recently created a Professional Interest Area (PIA) entitled "Clinical Trials Advancements and Outcomes" in the International Society to Advance Alzheimer's Research (ISTAART, an international AD research organization sponsored by the Alzheimer's Association). This PIA creates an international researchers' forum where innovative clinical trial approaches, developments of outcomes sensitive to trial effects, and unique non-pharmacological trials are being introduced and discussed. Her most recently completed NIA funded R01 examined whether stimulations through social interactions using modern communication technologies (pc, webcams and Internet) could improve cognitive functions. She holds Fellow status at the Gerontological Society of America and serves as a statistical editor for several dementia-related journals.

Karen Innes

Karen Innes, MSPH, Ph.D.

Associate Professor
Robert C. Byrd Health Sciences Center, Center on Aging
West Virginia University
Morgantown, West Virginia

As an epidemiologist and clinical researcher, Dr. Innes' work focuses on the etiology, prevention, and management of chronic, age-related disorders linked to stress, sympathetic activation, and metabolic dysregulation. Her current research includes clinical trials to investigate the potential utility of yoga in the prevention and management of chronic insulin resistance conditions, funded by grants from the NIH National Center for Complementary and Alternative Medicine and the Office of Research on Women’s Health, as well as research initiatives regarding the potential benefits of mind-body interventions in adults with early stage Alzheimer’s disease (and their caregivers), Parkinson’s disease, restless legs syndrome, and osteoarthritis. 

Additional research projects include investigations regarding the determinants, distribution, and sequellae of sleep impairment in both adolescents and older adults, including the role of sympathetic activation and metabolic dysregulation in the etiology and progression of specific sleep disorders, and more recently, the relation of specific environmental pollutants to the development of chronic, proinflammatory, age-related conditions, including cancer, diabetes, and osteoarthritis.

Sat Bir Singh Khalsa

Sat Bir Singh Khalsa, Ph.D.

Asst. Professor of Medicine
Harvard Medical School
Sleep Disorders Research Program, Brigham and Women’s Hospital
Boston, Massachusetts

Sat Bir Singh Khalsa, Ph.D., the KRI Director of Research, received his doctorate in human physiology and neuroscience at the University of Toronto and has conducted research in neuroscience, biological rhythms, sleep and sleep disorders for more than 25 years. He has been involved in the practice of yoga for more than 35 years and is a KRI certified Kundalini Yoga. He is currently an Assistant Professor of Medicine at Harvard Medical School in the Division of Sleep Medicine at Brigham and Women’s Hospital in Boston.

His current research is both basic and clinical and centers on the effectiveness of yoga and meditation practices; he is currently conducting clinical research trials evaluating a yoga treatment for insomnia funded by the National Center for Complementary and Alternative Medicine of the National Institutes of Health. In active collaboration with the Kripalu Center for Yoga and Health, he directs their research team and is involved in a current project that evaluates the benefits of yoga for professional musicians, among others. He has additional collaborations examining the role of yoga as a therapeutic treatment for conditions such as diabetes, stress, and cardiovascular disease.

Dr. Khalsa has established relationships with fellow yoga researchers in the US as well as in Europe and India, where he routinely attends and presents at international yoga research conferences. He also teaches Mind Body Medicine at Harvard Medical School, which provides medical students with direct exposure to Kundalini Yoga.

Miia Kivipelto

Miia Kivipelto, M.D., Ph.D.

Professor of Clinical Geriatric Epidemiology at Karolinska Institute
Deputy Head of the Aging Research Center
Stockholm, Sweden

Miia’s research focuses on prevention, early diagnosis and treatment of cognitive impairment, dementia and Alzheimer’s disease (AD). Through epidemiological studies she has identified midlife vascular and lifestyle risk factors for later dementia/AD and aims to build on these observations to improve knowledge transfer and public awareness and to design intervention trials to mitigate these factors including lifestyle manipulations, such as exercise interventions. Miia is principal investigator for the population-based study Cardiovascular Risk Factors, Aging and Dementia (CAIDE) and the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), one of the first multi-domain intervention studies in the world aimed at preventing or postponing dementia. She is also part of a Europe’s first-ever European Dementia Prevention Initiative (EDPI). 

Miia leads a group of multidisciplinary researchers that includes 4 postdocs and 9 doctoral students. Her group has close connections with the University of Eastern Finland and the National Institute of Health and Welfare in Helsinki and this collaboration has led to the development of the Nordic Brain Network (NBN), which has increased the utilization and exchange of resources and information about aging. She is also involved in many international networks and scientific/steering committees. Miia has received several awards including: Junior Chamber International: Ten Outstanding Young Persons of the World 2011; Academy of Finland Award for Social Impact 2009; The Association of European Psychiatrists and European Bristol-Myers Squibb Prevention Award in Psychiatry 2007 and Martti Hämäläinen’s Award for Young Researcher 2002.

Helen Lavretsky

Helen Lavretsky, M.D.

UCLA Semel Institute and Resnick Neuropsychiatric Hospital
Los Angeles, California

Helen Lavretsky, MD, is a Professor of Psychiatry in the Department of Psychiatry and Biobehavioral Sciences at UCLA, and the Semel Scholar in Integrative Mental Health. She directs a research program in Late-life depression, stress, and wellness program at the Semel Institute for Neuroscience and Human Behavior at UCLA. Dr. Lavretsky is a recipient of the career development and other research awards from National Institute of Mental Health (NIMH) and the National Center for Complementary and Integrative Health (NCCIH), and other research grants. Her current research interest is in developing mind-body approaches to treatment and prevention of mood and cognitive disorders in older adults using medications, memory training, exercise, Tai-Chi, yoga and meditation.

After receiving her Medical Degree from the Moscow Medical Institute, Dr. Lavretsky performed her residency in Psychiatry at UCLA-San Fernando Valley Residency Program, followed by the UCLA Fellowship in Geriatric Psychiatry, and the national VA Research Fellowship in Neurosciences. She received her Degree of Master of Science in Clinical Research from UCLA in 2004. She is Board-certified by the American Board of Psychiatry and Neurology with added Geriatric Qualifications, and by the American Board of Holistic and Integrative Medicine. She is a Distinguished Fellow of the American Psychiatric Association and a Fellow of the American College of Neuropsychopharmacology.

Arti Prasad, MD, FACP

Arti Prasad MD, FACP

Chief, Division of General Internal Medicine, Geriatrics, and Integrative Medicine
Founding Executive Director of UNM Center for Life
University of New Mexico Health Sciences Center
Albuquerque, New Mexico

Dr. Arti Prasad is a Professor of Internal Medicine and is involved in faculty development, community outreach, CME at the UNM School of Medicine and teaches in different phases of medical education. She organizes and Chairs the Biennial Symposium of Integrative Medical Professionals in the Land of Enchantment (SIMPLE). Dr. Prasad has received grant support every year from 2010-2014 to develop and support an Integrative Medicine Track in the Internal Medicine Residency program at UNM. The track is the first program of its kind in the nation.

Under her leadership, UNM School of Medicine became one of the earlier members of the Academic Consortium of Integrative Medicine and Health. Dr. Prasad was nominated and selected in 2015 as one of the founding board members to the new American Board of Integrative Medicine (ABOIM).

The most important and fulfilling aspect of Dr. Prasad's career is providing patient-centered and compassionate care to her patients; creating and expanding new programs; fund-raising; and mentoring and coaching her faculty, colleagues, staff, residents, and students.

Michelle Sierpina

Michelle Sierpina, Ph.D.

Founding Director, UTMB Osher Institute for Lifelong Learning
University of Texas Medical Branch
Galveston, Texas

Dr. Michelle Sierpina, Founding Director of Osher Lifelong Learning Institute (OLLI) at (UTMB) in Galveston, Texas, began her work in eldercare in the 1960’s. She developed a series of lifestory writing and sharing group modalities which, taken together, form The Pentimento Project. Combining lifestory with Visible Lives storyboard intervention, and TimeSlips©, storytelling group modality for those with dementia, she offers facilitator training in UTMB’s Creativity Continuum to health care professionals, lay persons, and volunteers in Texas and around the country. She guides others in forming and leading lifestory groups from New York to Nevada and New Zealand to Greece and recently Italy and Russia.

She has taught at UT Houston Center on Aging, University of Nevada, Reno, St. George’s Medical University in Grenada, and at conferences around the nation, as well as in UTMB’s Institute for the Medical Humanities and School of Nursing Graduate Program. Sierpina has published peer-reviewed articles and book chapters on topics in gerontology, spirituality, and creativity in elders. Continuing her research on lifestory writing and sharing groups, she studies and nurtures creativity among elders across the entire continuum of functional capability.

Under her leadership, OLLI at UTMB has received three consecutive $100,000 annual grants from the Bernard Osher Foundation and a $1 million endowment (with $50,000 bridge funding) in 2008.